4//SEC Filing
Jack Eva M. 4
Accession 0001104659-20-105768
CIK 0001442836other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 6:31 PM ET
Size
8.7 KB
Accession
0001104659-20-105768
Insider Transaction Report
Form 4
Jack Eva M.
CBO, Treasurer & Secretary
Transactions
- Sale
Common Stock
2020-09-14$22.00/sh−35,248$775,456→ 0 total - Exercise/Conversion
Common Stock
2020-09-14$1.53/sh+35,248$53,929→ 35,248 total - Exercise/Conversion
Stock Option (right to buy)
2020-09-14−35,248→ 35,248 totalExercise: $1.53Exp: 2025-11-06→ Common Stock (35,248 underlying)
Footnotes (3)
- [F1]The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 7, 2020.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 7, 2020.
- [F3]The options vested in equal quarterly installments over the first four years after the vesting commencement date, June 12, 2015.
Documents
Issuer
Mersana Therapeutics, Inc.
CIK 0001442836
Entity typeother
Related Parties
1- filerCIK 0001709771
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 6:31 PM ET
- Size
- 8.7 KB